Advanced Search


Study ID Status Title Patient Level Data
112933 Completed Booster vaccination with pneumococcal vaccine GSK1024850A or Prevenar™ co-administered with Hiberix™ in children primed with the same vaccines Study Listed on
112934 Completed A Phase I, open label, randomized, three period, one-way, two cohort, adaptive crossover study to evaluate the effect of darunavir/ritonavir plus etravirine and lopinavir/ritonavir plus etravirine on GSK1349572 pharmacokinetics in healthy adult subjects (ING112934)
112937 Completed Retrospektive Studie zu Patientinnen, die pränatal, perinatal oder postnatal prophylaktisch oder therapeutisch mit Fondaparinux behandelt wurden
112940 Relinquished A longitudinal 2-year bone marrow study of eltrombopag olamine (SB-497115-GR) in previously treated adults, with chronic immune (idiopathic) thrombocytopenic purpura (ITP)
112941 Completed A randomized, double-blind study to evaluate the safety, tolerability, and pharmacokinetics of a supratherapeutic dose of GSK1349572 250 mg and a randomized, open-label study to evaluate the effects of omeprazole 40 mg daily and a high fat meal on the pharmacokinetics of GSK1349572 50 mg in healthy adult subjects (ING112941)
112949 Completed Long-term extension study of the efficacy of the 580299 vaccine in the prevention of HPV-16 and/or HPV-18 associated cervical intraepithelial neoplasia (CIN) in Japanese women vaccinated in the primary vaccination study NCT00316693 Study Listed on
112951 Completed Occurrence of brain metastasis in breast cancer patients diagnosed at advanced stages of the disease
112956 Terminated Identification and characterisation of bacteria causing chronic cough among children in the United Kingdom
112957 Completed Phase III, partially double-blind study to evaluate consistency and immunogenicity of 3 lots of GSK Biologicals' Hib conjugate vaccine 208108 versus ActHIB and Pentacel at 2, 4, 6 and 15-18 months of age in healthy infants Study Listed on
112958 Completed A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects with post-stroke upper limb spasticity
112961 Completed A pilot study to assess the antiviral activity of GSK1349572 containing regimen in antiretroviral therapy (ART)-experienced, HIV-1-infected adult subjects with raltegravir resistance
112963 Completed Immunogenicity, Reactogenicity and Safety of GSK Biologicals' Quadrivalent Influenza Vaccine FLU Q-QIV (GSK2282512A) When Administered Intramuscularly to Adults 18 Years of Age and Older Study Listed on
112967 Completed A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from peripheral nerve injury Study Listed on
112980 Withdrawn Immunogenicity and safety of a birth dose of GlaxoSmithKline Biologicals’ reduced-antigen-content tri-component pertussis (251154) vaccine
112988 Terminated A randomized, single-blind (Investigator and Subject), placebo-controlled, single ascending dose study exploring the preliminary safety, tolerability, and pharmacokinetics of GSK1223249 administered by intravenous (IV) infusion to subjects with relapsing forms of multiple sclerosis, not on disease modifying therapy
112989 Completed Validation of a New Shortness of Breath with Daily Activities Questionnaire in patients with Chronic Obstructive Pulmonary Disease Study Listed on
112993 Completed A study to evaluate safety and immunogenicity of a booster dose of two formulations of GSK Biologicals’ pneumococcal candidate vaccine in healthy young adults Study Listed on
112994 Completed An epidemiological study to evaluate the incidence, clinical characteristics and economic burden of dengue in Brazilian children
112997 Completed A multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to determine the effect of mepolizumab on exacerbation rates in subjects with severe uncontrolled refractory asthma Study Listed on
112999 Completed Immunogenicity & safety study of GSK Biologicals’ thimerosal-free trivalent influenza vaccine (TIV) versus a licensed comparator in children Study Listed on
113006 Completed A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-centre, Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod (GW856553) Tablets Administered Twice Daily compared with Placebo for 24 Weeks in Adult Subjects with Chronic Obstructive Pulmonary Disease Study Listed on
113009 Completed A six week randomized, double-blind, multi-center, placebo-controlled, exploratory, adaptive design study to explore the antidepressant properties of the p38 MAP kinase inhibitor GW856553 compared to placebo in adult subjects with Major Depressive Disorder Study Listed on
113018 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in people aged 18 years or above Study Listed on
113020 Completed A Proof of Concept Study for GSK2248761 (An Extension of NV-05A-002: A Phase I/IIa Double-Blind Study to Evaluate the Safety and Tolerability, Antiretroviral Activity, Pharmacokinetics and Pharmacodynamics of IDX12899 in Antiretroviral Treatment-Naive HIV-1 Infected Subjects, completed by Idenix)
113022 Completed Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of single intravenous dose(s) and a single oral dose of GW856553 in healthy volunteers Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.